GM-103(GeneMedicine)

N/A

Report date: 2024/02/21 20:01:04

Base Information

Drug NameGM-103(GeneMedicine)
Drug Alias NameGM-103
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vectorBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicityAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenemedicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenemedicine Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A